Summary report on the graded prognostic assessment: An accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases

Journal of Clinical Oncology

Volumn 30, Issue 4, 2012, Pages 419-425

  Sperduto, Paul W ^a   Kased, Norbert ^c   Roberge, David ^o   Xu, Zhiyuan ^d   Shanley, Ryan ^a   Luo, Xianghua ^a   Sneed, Penny K ^c   Chao, Samuel T ^d   Weil, Robert J ^d   Suh, John ^d   Bhatt, Amit ^e   Jensen, Ashley W ^b   Brown, Paul D ^b   Shih, Helen A ^f   Kirkpatrick, John ^h   Gaspar, Laurie E ⁱ   Fiveash, John B ^j   Chiang, Veronica ^k   Knisely, Jonathan P S ^l   Sperduto, Christina Maria ^m   Lin, Nancy ^g   Mehta, Minesh ⁿ   more..

^a UNIVERSITY OF MINNESOTA   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g DANA FARBER CANCER INSTITUTE   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^k YALE CANCER CENTER   (United States)

^l DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^m DARTMOUTH COLLEGE   (United States)

ⁿ NORTHWESTERN UNIVERSITY   (United States)

^o MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN METASTASIS; BREAST CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL ASSESSMENT TOOL; DIAGNOSTIC ACCURACY; DIGESTIVE SYSTEM CANCER; GRADED PROGNOSTIC ASSESSMENT; HUMAN; KARNOFSKY PERFORMANCE STATUS; KIDNEY CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MELANOMA; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURVIVAL TIME;

BRAIN NEOPLASMS; BREAST NEOPLASMS; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MALE; MELANOMA; NEOPLASM GRADING; NEOPLASM METASTASIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84863020427     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.38.0527     Document Type: Article

References (18)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics 2008. CA Cancer J Clin 58:71-96, 2008
2. Zimm S, Wampler GL, Stablein D, et al: Intracerebral metastases in solid-tumor patients: Natural history and results of treatment. Cancer 48:384-394, 1981 (Pubitemid 11127382)
3. Posner JB: Neurologic Complications of Cancer. Philadelphia, PA, FA Davies, 1995
4. Gaspar LE, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745-751, 1997 (Pubitemid 27181303)
5. Gaspar LE, Scott C, Murray K, et al: Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47:1001-1006, 2000 (Pubitemid 30345599)
6. Sperduto PW, Berkey B, Gaspar LE, et al: A new prognostic index and comparison to three other indices for patients with brain metastases: An analysis of 1960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 70:510-514, 2008
7. Komarnicky LT, Phillips TL, Martz K, et al: A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG79-16). Int J Radiat Oncol Biol Phys 20:53-58, 1991
8. Sause WT, Scott C, Kirsch R, et al: Phase I/II trial of accelerated fractionation in brain metastases, RTOG 85-28. Int J Radiat Oncol Biol Phys 26:653-657, 1993 (Pubitemid 23220165)
9. Phillips TL, Scott CB, Leibel S, et al: Results of a randomized comparison of radiotherapy and bromodeoxyuridine to radiotherapy alone for brain metastases: Report of RTOG trial 89-05. Int J Radiat Oncol Biol Phys 33:339-348, 1995
10. Murray KJ, Scott C, Greenberg HM, et al: A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: A report of RTOG 9104. Int J Radiat Oncol Biol Phys 39:571-574, 1997 (Pubitemid 27441421)
11. Sperduto CM, Watanabe Y, Mullan J, et al: A validation study of a new prognostic index for patients with brain metastases: The graded prognostic assessment. J Neurosurg 109:87-89, 2008
12. Sperduto PW, Chao ST, Sneed PK, et al: Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: A multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 77:655-661, 2010
13. Sperduto PW: What is your patient's GPA and why does it matter? Managing brain metastases and the cost of hope. Int J Radiat Oncol Biol Phys 77:643-644, 2010
14. Sperduto PW, Kased N, Roberge D, et al: The effect of tumor subtype on survival and the Graded Prognostic Assessment (GPA) for patients with breast cancer and brain metastases. Int J Radiat Oncol Biol Phys 10.1016/j.ijrobp.2011. 02.027 [epub ahead of print on April 14, 2011]
15. van Dijk MR, Steyerberg EW, Stenning SP, et al: Survival of patients with nonseminomatous germ cell cancer: A review of the IGCC classification by Cox regression and recursive partitioning. Br J Cancer 90:1176-1183, 2004 (Pubitemid 38496810)
16. Breiman L, Friedman JH, Olshen RA, et al: Classification and Regression Trees. Monterey, CA, Wadsworth, 1984
17. Therneau TM, Atkinson EJ: An Introduction to Recursive Partitioning Using the rpart Routine. Technical Report 61. Rochester, MN, Section of Biostatistics, Mayo Clinic, 1997
18. Osler W: Chauvinism in medicine, in Aequanimitas and Other Addresses. Philadelphia, PA, P. Blakiston's Son & Co, 1928, p 300